Cardio Conversations: iRhythm Aspires To ‘Standard-Of-Care’ Monitoring

Quentin Blackford, CEO of iRhythm, talked to Medtech Insight about his company’s plans to bring its Zio long-term cardiac monitoring platform to more patients by building its evidence base and marketing in more countries outside the US. For more information on iRhythm, cardiac monitoring and ECG technologies, check out these articles at Medtech Insight. Cardio Conversations: Vektor Addresses ‘Global Health Crisis’ With Arrythmia Mapping https://medtech.pharmaintelligence.informa.com/MT147825/Cardio-Conversations-Vektor-Addresses-Global-Health-Crisis-With-Arrythmia-Mapping CMS Proposes National Payments For Long-Term Continuous Electrocardiogram Monitoring https://medtech.pharmaintelligence.informa.com/MT145597/CMS-Proposes-National-Payments-For-Long-Term-Continuous-Electrocardiogram-Monitoring FDA Clears iRhythm’s Afib-Detecting Wearable Running Software Co-Developed By Verily https://medtech.pharmaintelligence.informa.com/MT145646/FDA-Clears-iRhythms-Afib-Detecting-Wearable-Running-Software-Co-Developed-By-Verily Exec Chat: As Reimbursement Questions Get Answers, iRhythm Looks To The Future https://medtech.pharmaintelligence.informa.com/MT145401/Exec-Chat-As-Reimbursement-Questions-Get-Answers-iRhythm-Looks-To-The-Future JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet https://medtech.pharmaintelligence.informa.com/MT144935/JPM-2022-Abbott-iRhythm-Novocure-Zimmer-Biomet Exec Chat: New iRhythm CEO Foresees Enormous Opportunity In AI For Arrhythmia Detection https://medtech.pharmaintelligence.informa.com/MT144913/Exec-Chat-New-iRhythm-CEO-Foresees-Enormous-Opportunity-In-AI-For-Arrhythmia-Detection Dexcom COO Quentin Blackford Takes CEO Job At iRhythm https://medtech.pharmaintelligence.informa.com/MT144461/Dexcom-COO-Quentin-Blackford-Takes-CEO-Job-At-iRhythm